Stay updated on Pembrolizumab for Metastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T06:26:50.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new collaborators and a revision of the study version. Notably, the detailed objectives and treatment phases related to pembrolizumab for metastatic castration-resistant prostate cancer have been removed.
    Difference
    45%
    Check dated 2025-04-15T20:44:36.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has updated its version from v2.14.3 to v2.14.4 and removed a date of March 25, 2025, while adding dates of January 20, 2025, and March 13, 2025.
    Difference
    0.3%
    Check dated 2025-04-08T17:11:15.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version release and the most recent update date, indicating a shift in the versioning and timing of the content.
    Difference
    0.3%
    Check dated 2025-04-01T13:29:00.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The webpage has updated its date references, adding new dates in March 2025 while removing older dates from January 2025.
    Difference
    0.4%
    Check dated 2025-03-18T01:58:05.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-02-24T13:28:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Metastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.